Business Context and Reporting Period
This Form 8-K was filed by Triumph Bancorp, Inc. on May 11, 2017. The report addresses a corporate governance matter regarding the composition of the Company's Audit Committee and its compliance with NASDAQ listing standards.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance status rather than financial performance.
Material Changes
The material change reported is the reduction of the Audit Committee to two members following the decision of member Derek McClain not to stand for re-election at the Annual Meeting. Consequently, the Company received a notice from The NASDAQ Stock Market on May 11, 2017, acknowledging non-compliance with Listing Rule 5605(c)(2)(A), which requires an audit committee of at least three independent directors.
Outlook, Risks, and Management Commentary
Management intends to fill the vacancy on the Audit Committee within the cure period provided under Listing Rule 5605(c)(4)(B) of The NASDAQ Stock Market. The primary risk identified is the potential delisting or failure to satisfy continued listing rules if the vacancy is not filled within the specified timeframe. No other risks, contingencies, or unusual items were disclosed in this filing.
Key Facts for Investor Verification
- Verify the timeline for appointing a new independent director to the Audit Committee to ensure compliance with the NASDAQ cure period.
- Confirm the current status of the Audit Committee composition in subsequent filings.
- Note that this filing does not contain financial results or guidance for the period.